Western Slope Laboratory’s research, development and testing capabilities make it a valuable collaborative partner for established distribution networks/channels that benefit from globalization of markets, including the health care market. Making laboratory developed tests, like our patented saliva-based heavy metal test, available for wide-scale screening efforts in markets such as Asia-Pacific and South America is dependent, solely, on the availability and stability of distribution networks.
We believe pressures will continue to mount for the development of worldwide communication, distribution and information networks prompted, mainly, by e-commerce. Web-based international distribution of Western Slope Laboratory testing capability is an avenue currently under consideration.
It is our desire to work with professional, ethical and well-established distribution networks capable of multiple-market penetration.
Western Slope Laboratory’s accreditation to the ISO/IEC 17025 standard comes with recognized equivalency to many other countries’ internal accreditation requirements. For example, in the United Kingdom, the accrediting agency for laboratories like Western Slope is UKAS. UKAS recognizes our accreditation as equivalent to its. This is true for many countries worldwide.